Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial respiratory chain function in multiple system atrophy

M Gu1, M T Gash, J M Cooper

  • 1Department of Clinical Neurosciences, Royal Free Hospital School of Medicine, London, England.

Movement Disorders : Official Journal of the Movement Disorder Society
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons.

Scientific reports·2018
Same author

Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces.

European journal of neurology·2015
Same author

The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.

AJNR. American journal of neuroradiology·2014
Same author

The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.

AJNR. American journal of neuroradiology·2014
Same author

Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats.

Neurobiology of disease·2013
Same author

Colloidal gold staining and immunodetection in 2-d protein mapping.

Methods in molecular biology (Clifton, N.J.)·2012
Same journal

Key Interventions in Friedreich's Ataxia and Their Impact on Patient Outcomes: A Systematic Review.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Reply to Comment on: "Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease".

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same journal

Alzheimer's Disease Cerebrospinal Fluid Biomarkers Predict Survival in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026
See all related articles

Multiple system atrophy (MSA) does not show the mitochondrial complex I defect seen in Parkinson's disease (PD). L-DOPA treatment in MSA patients did not induce this defect, suggesting it's not the cause in PD.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Mitochondrial Biology

Background:

  • Multiple system atrophy (MSA) and Parkinson's disease (PD) are distinct parkinsonism disorders.
  • Both conditions involve nigral neuron degeneration.
  • PD substantia nigra shows a specific deficiency in mitochondrial complex I activity.

Purpose of the Study:

  • To investigate mitochondrial function in MSA substantia nigra and platelets.
  • To identify respiratory chain defects in MSA.
  • To determine if L-DOPA treatment causes complex I defects in MSA, similar to PD.

Main Methods:

  • Analysis of mitochondrial respiratory chain activity in substantia nigra and platelets from MSA patients and controls.
  • Correction for mitochondrial mass to ensure accurate comparison.

Related Experiment Videos

  • Assessment of L-DOPA's effect on mitochondrial function in MSA.

    • Main Results:

    • No significant difference in respiratory chain activity (corrected for mitochondrial mass) was found between MSA and control patients in either tissue.
    • L-DOPA treatment in MSA patients did not induce a complex I defect in the substantia nigra.

    Conclusions:

    • The findings provide biochemical evidence differentiating MSA from idiopathic PD.
    • The lack of L-DOPA-induced complex I defect in MSA suggests this treatment is unlikely to be the sole cause of complex I deficiency in PD.
    • Additional factors may be involved in the pathogenesis of complex I deficiency in PD.